Tirzepatide Tirzepatide is a dual-action peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering advanced metabolic and weight management support.
Suppresses glucagon secretion, delayed gastric emptying, and excessive food intake, supporting sustainable weight reduction and metabolic balance. May improve body composition, cardiometabolic health, hemoglobin A1c levels, and overall energy regulation when combined with lifestyle interventions.
Regulates blood sugar levels, insulin sensitivity, and appetite by enhancing glucose-dependent insulin secretion and promoting satiety. Effective in managing type 2 diabetes, pre-diabetes, and obesity , with superior weight loss outcomes compared to GLP-1 monotherapy.
19
Made with FlippingBook Ebook Creator